{
  "pmid": "24952856",
  "uid": "24952856",
  "title": "Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial.",
  "abstract": "Patients with cardiovascular disease and impaired glucose tolerance are at increased risk of cardiovascular events and type 2 diabetes mellitus (T2DM). Lifestyle modification or pharmacological intervention can delay progression to T2DM, but there is no clear evidence that they reduce cardiovascular risk in this population. Acarbose, an α-glucosidase inhibitor that lowers postprandial blood glucose, has been shown to reduce T2DM risk by 25%, and possibly cardiovascular risk in impaired glucose tolerance subjects without cardiovascular disease.",
  "authors": [
    {
      "last_name": "Holman",
      "fore_name": "Rury R",
      "initials": "RR",
      "name": "Rury R Holman",
      "affiliations": [
        "Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom. Electronic address: rury.holman@dtu.ox.ac.uk."
      ]
    },
    {
      "last_name": "Bethel",
      "fore_name": "Mary A",
      "initials": "MA",
      "name": "Mary A Bethel",
      "affiliations": [
        "Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom."
      ]
    },
    {
      "last_name": "Chan",
      "fore_name": "Juliana C N",
      "initials": "JC",
      "name": "Juliana C N Chan",
      "affiliations": [
        "Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong."
      ]
    },
    {
      "last_name": "Chiasson",
      "fore_name": "Jean-Louis",
      "initials": "JL",
      "name": "Jean-Louis Chiasson",
      "affiliations": [
        "CRCHUM, Department of Medicine, University of Montreal, Montreal, Canada."
      ]
    },
    {
      "last_name": "Doran",
      "fore_name": "Zoë",
      "initials": "Z",
      "name": "Zoë Doran",
      "affiliations": [
        "Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom."
      ]
    },
    {
      "last_name": "Ge",
      "fore_name": "Junbo",
      "initials": "J",
      "name": "Junbo Ge",
      "affiliations": [
        "Zhongshan Hospital, Fudan University, Shanghai, China."
      ]
    },
    {
      "last_name": "Gerstein",
      "fore_name": "Hertzel",
      "initials": "H",
      "name": "Hertzel Gerstein",
      "affiliations": [
        "Department of Medicine and Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada."
      ]
    },
    {
      "last_name": "Huo",
      "fore_name": "Yong",
      "initials": "Y",
      "name": "Yong Huo",
      "affiliations": [
        "Department of Cardiology, Peking University First Hospital, Beijing, China."
      ]
    },
    {
      "last_name": "McMurray",
      "fore_name": "John J",
      "initials": "JJ",
      "name": "John J McMurray",
      "affiliations": [
        "Institute of Cardiovascular & Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom."
      ]
    },
    {
      "last_name": "Ryden",
      "fore_name": "Lars",
      "initials": "L",
      "name": "Lars Ryden",
      "affiliations": [
        "Cardiology Unit, Karolinska University Hospital Solna, Stockholm, Sweden."
      ]
    },
    {
      "last_name": "Liyanage",
      "fore_name": "Winitha",
      "initials": "W",
      "name": "Winitha Liyanage",
      "affiliations": [
        "Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom."
      ]
    },
    {
      "last_name": "Schröder",
      "fore_name": "Stefan",
      "initials": "S",
      "name": "Stefan Schröder",
      "affiliations": [
        "Bayer Healthcare, Bayer Pharma AG, Berlin, Germany."
      ]
    },
    {
      "last_name": "Tendera",
      "fore_name": "Michal",
      "initials": "M",
      "name": "Michal Tendera",
      "affiliations": [
        "3rd Division of Cardiology, Medical University of Silesia, Katowice, Poland."
      ]
    },
    {
      "last_name": "Theodorakis",
      "fore_name": "Michael J",
      "initials": "MJ",
      "name": "Michael J Theodorakis",
      "affiliations": [
        "Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom."
      ]
    },
    {
      "last_name": "Tuomilehto",
      "fore_name": "Jaakko",
      "initials": "J",
      "name": "Jaakko Tuomilehto",
      "affiliations": [
        "Centre for Vascular Prevention, Danube-University Krems, Krems, Austria; Diabetes Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland; King Abdulaziz University, Jeddah, Saudi Arabia."
      ]
    },
    {
      "last_name": "Yang",
      "fore_name": "Wenying",
      "initials": "W",
      "name": "Wenying Yang",
      "affiliations": [
        "China-Japan Friendship Hospital, Beijing, China."
      ]
    },
    {
      "last_name": "Hu",
      "fore_name": "Dayi",
      "initials": "D",
      "name": "Dayi Hu",
      "affiliations": [
        "People's Hospital of Peking University, Beijing, China."
      ]
    },
    {
      "last_name": "Pan",
      "fore_name": "Changyu",
      "initials": "C",
      "name": "Changyu Pan",
      "affiliations": [
        "Department of Endocrinology, People's Liberation Army General Hospital, Beijing, China."
      ]
    },
    {
      "affiliations": []
    }
  ],
  "journal": {
    "title": "American heart journal",
    "iso_abbreviation": "Am Heart J",
    "issn": "1097-6744",
    "issn_type": "Electronic",
    "volume": "168",
    "issue": "1",
    "pub_year": "2014",
    "pub_month": "Jul"
  },
  "start_page": "23",
  "end_page": "9.e2",
  "pages": "23-9.e2",
  "language": "eng",
  "publication_types": [
    "Journal Article",
    "Multicenter Study",
    "Randomized Controlled Trial",
    "Research Support, Non-U.S. Gov't"
  ],
  "keywords": [
    "Acarbose",
    "Blood Glucose",
    "Coronary Disease",
    "Diabetes Mellitus, Type 2",
    "Disease Progression",
    "Double-Blind Method",
    "Follow-Up Studies",
    "Glucose Intolerance",
    "Humans",
    "Hypoglycemic Agents",
    "Prospective Studies",
    "Secondary Prevention",
    "Treatment Outcome"
  ],
  "article_ids": {
    "pubmed": "24952856",
    "doi": "10.1016/j.ahj.2014.03.021",
    "pii": "S0002-8703(14)00167-7"
  },
  "doi": "10.1016/j.ahj.2014.03.021",
  "dates": {
    "completed": "2014-09-02",
    "revised": "2014-06-23"
  },
  "chemicals": [
    "Blood Glucose",
    "Hypoglycemic Agents",
    "Acarbose"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "current_affiliation",
    "retrieved_date": "2025-07-30T14:22:49.679155",
    "pmid": "24952856"
  }
}